News
-
Data from Boehringer Ingelheims ANHELTO 1 and ANHELTO 2 studies demonstrate that co-administration of the Spiriva HandiHaler tiotropium DPI and the Striverdi Respimat olodaterol SMI produced significantly greater improvement in the lung function of COPD… Read more . . .
-
Grupo Ferrer Internacional, which markets Alexza Pharmaceuticals’ Adasuve inhaled loxapine in the EU, Latin America, and the CIS countries, will acquire 2 million shares of Alexza common stock at $4 per share, the companies have… Read more . . .
-
Ferring Pharmaceuticals has announced that it has reacquired desmopressin acetate (DDAVP), which is approved as a nasal spray and a number of other formulations, from Sanofi. Ferring originally developed desmopressin, which is a synthetic form… Read more . . .
-
Device manufacturer Gerresheimer has announced the opening of a new development center in Dongguan City, China, where the company has been manufacturing inhalers and other drug delivery devices since 2006. The company also has development… Read more . . .
-
According to Swedish device developer Iconovo, the company has raised $1 million in venture capital that it will use for development of dry powder inhalation devices. The company also said that Lennart Holm, chairman of… Read more . . .
-
FSC Laboratories has announced that its Flexichamber collapsible valved holding chamber has received FDA clearance for use with most pMDIs. The device, which can be used with or without a mask, will be available by… Read more . . .
-
Results from a 24-week study comparing GSK’s Anoro Ellipta umeclidinium /vilanterol DPI to Boehringer Ingelheim’s Spiriva Handihaler tiotropium DPI published in Respiratory Medicine show statistically greater improvement in trough FEV1 and weighted mean FEV1 0… Read more . . .
-
Retrophin has announced that Turing Pharmaceuticals will pay $3 million up front for three of Retrophin’s products, including Syntocinon oxytocin nasal spray and ketamine. According to the company, the agreement includes the resignation of Retrophin… Read more . . .
-
Novel Laboratories, Inc. is a fast growing specialty pharmaceutical products development and manufacturing company located in New Jersey. We are looking for experienced, senior level scientists/formulators/engineers for the development of Metered Dose Inhalers, Nasal Sprays… Read more . . .
-
Swedish CRO Inhalation Sciences AB (ISAB) has announced the hires of Mikael Mikko as a product specialist and Iwona Rådberg as an ex vivo and in vivo studies specialist. Mikko, who has a doctorate in… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA